These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5928460)

  • 1. Treatment of persistent endometrial hyperplasia with progestins.
    Wentz WB
    Am J Obstet Gynecol; 1966 Dec; 96(7):999-1004. PubMed ID: 5928460
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial hyperplasia in young women.
    Chamlian DL; Taylor HB
    Obstet Gynecol; 1970 Nov; 36(5):659-66. PubMed ID: 5473992
    [No Abstract]   [Full Text] [Related]  

  • 3. Progestin therapy in endometrial hyperplasia.
    Wentz WB
    Gynecol Oncol; 1974 Aug; 2(2-3):362-7. PubMed ID: 4457410
    [No Abstract]   [Full Text] [Related]  

  • 4. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
    Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
    Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The connection between endometrial glandular hyperplasia and the development of uterine cancer].
    Tabachnik BI
    Vopr Onkol; 1967; 13(9):40-7. PubMed ID: 5599603
    [No Abstract]   [Full Text] [Related]  

  • 6. A predictable case of endometrial carcinoma.
    Coltart TM; Scott DJ; Turner DR; Vale J
    Guys Hosp Rep; 1972; 121(4):333-42. PubMed ID: 4668420
    [No Abstract]   [Full Text] [Related]  

  • 7. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliation of metastatic endometrial adenocarcinoma with dimethisterone.
    Morrison J; Blunt VA
    Aust N Z J Obstet Gynaecol; 1972 Feb; 12(1):27-9. PubMed ID: 4112032
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.
    Ferenczy A; Gelfand M
    Am J Obstet Gynecol; 1989 Jan; 160(1):126-31. PubMed ID: 2912075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many endometrial cancer may develop from hyperplasia?
    Surico N; Viale S; Crivello T; Amedeo MC; Porcelli A
    Panminerva Med; 1988; 30(4):225-30. PubMed ID: 3244475
    [No Abstract]   [Full Text] [Related]  

  • 13. Endometrial hyperplasia treated by progestins.
    Eichner E; Abellera M
    Obstet Gynecol; 1971 Nov; 38(5):739-42. PubMed ID: 5114224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.
    Gunderson CC; Fader AN; Carson KA; Bristow RE
    Gynecol Oncol; 2012 May; 125(2):477-82. PubMed ID: 22245711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia.
    Lindahl B; Willén R
    Anticancer Res; 1998; 18(5B):3793-5. PubMed ID: 9854498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial hyperplasia with secretory changes.
    Tresserra F; Lopez-Yarto M; Grases PJ; Ubeda A; Pascual MA; Labastida R
    Gynecol Oncol; 2003 Mar; 88(3):386-93. PubMed ID: 12648591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.